Abstract | RATIONALE: OBJECTIVES: Our goal was to directly compare the activity of a standard second-line drug regimen with or without the addition of clofazimine in a mouse model of multidrug-resistant tuberculosis. Our comparative outcomes included time to culture conversion in the mouse lungs and the percentage of relapses after treatment cessation. METHODS: Mice were aerosol-infected with an isoniazid-resistant (as a surrogate of multidrug-resistant) strain of Mycobacterium tuberculosis. Treatment, which was administered for 5 to 9 months, was initiated 2 weeks after infection and comprised the following second-line regimen: daily (5 d/wk) moxifloxacin, ethambutol, and pyrazinamide, supplemented with amikacin during the first 2 months. One-half of the mice also received daily clofazimine. The decline in lung bacterial load was assessed monthly using charcoal-containing agar to reduce clofazimine carryover. Relapse was assessed 6 months after treatment cessation. MEASUREMENTS AND MAIN RESULTS: After 2 months, the bacillary load in lungs was reduced from 9.74 log10 at baseline to 3.61 and 4.68 in mice treated with or without clofazimine, respectively (P < 0.001). Mice treated with clofazimine were culture-negative after 5 months, whereas all mice treated without clofazimine remained heavily culture-positive for the entire 9 months of the study. The relapse rate was 7% among mice treated with clofazimine for 8 to 9 months. CONCLUSIONS: The clofazimine contribution was substantial in these experimental conditions.
|
Authors | Jacques H Grosset, Sandeep Tyagi, Deepak V Almeida, Paul J Converse, Si-Yang Li, Nicole C Ammerman, William R Bishai, Donald Enarson, Arnaud Trébucq |
Journal | American journal of respiratory and critical care medicine
(Am J Respir Crit Care Med)
Vol. 188
Issue 5
Pg. 608-12
(Sep 01 2013)
ISSN: 1535-4970 [Electronic] United States |
PMID | 23822735
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Antitubercular Agents
- Clofazimine
|
Topics |
- Animals
- Antitubercular Agents
(therapeutic use)
- Clofazimine
(therapeutic use)
- Drug Resistance, Multiple, Bacterial
- Female
- Lung
(microbiology)
- Mice
- Mice, Inbred BALB C
- Microbial Sensitivity Tests
- Mycobacterium tuberculosis
(drug effects)
- Recurrence
- Tuberculosis, Pulmonary
(drug therapy)
|